gip and glp-1 hormones The dual glucose-dependent insulinotropic polypeptide (GIP) glucagon-like peptide-1 (GLP-1) receptor agonist tirzepatide: a novel cardiometabolic therapeutic prospect | Cardiovascular Diabetology Gut hormone-based pharmacology: novel formulations

Step-by-step UK guidance on injectable and oral GLP-1 medications, dosage, storage, and managing side effects for diabetes and weight management.

Compared with other second- or third-line glucose-lowering medications, the GLP-1RAs demonstrated a lower rate of adverse CVEs, including heart failure (HR 0.88

Among non-diabetic patients without chronic kidney disease (CKD), there was a minimal increase of 0.01 mg/dL to 0.02 mg/dL in serum creatinine in the months following initiation of semaglutide, liraglutide, or tirzepatide

Type 2 diabetes mellitus (T2DM) is a complex metabolic disorder, primarily characterized by a decrease in insulin secretion and typically accompanied by insulin resistance

Most state Medicaid programs dont cover weight loss drugs for obesity, but that could soon change.

How do yall find relief and manage? one member asked.While theres not yet a cure for hidra